Switch to
View more

SeQuent Scientific Ltd

SEQUENT
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,657 cr, stock is ranked 669
High RiskStock is 3.36x as volatile as Nifty
106.952.85 (+2.74%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,657 cr, stock is ranked 669
High RiskStock is 3.36x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
64.44
PB RatioPB Ratio
3.42
Dividend YieldDiv. Yield
Sector PESector PE
38.16
Sector PBSector PB
4.82
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

SeQuent Scientific Limited is a holding company that operates in pharmaceutical sector.

Financial TrendFinancial statements 

20192020202120221.051.191.371.420.050.070.100.04
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Newspaper Advertisements 
Announced OnAug 10, 2022

Sequent Scientific Limited has informed the Exchange about Newspaper Advertisement published on August 10, 2022, in ¬タリFinancial Express¬タル and ¬タリMumbai Lakshadeep¬タル newspaper providing Extracts of Unaudited Financial Results of the Company for the quarter ended June 30, 2022. | Download

Sequent Scientific Limited has informed the Exchange about Newspaper Advertisement published on August 10, 2022, in ¬タリFinancial Express¬タル and ¬タリMumbai Lakshadeep¬タル newspaper providing Extracts of Unaudited Financial Results of the Company for the quarter ended June 30, 2022. | Download

Recording of Analysts/Institutional Investor Meet/Con. Call 
Announced OnAug 9, 2022

Sequent Scientific Limited has informed the Exchange that the Recording of Analysts/Institutional Investor Meet/Con. Call held on August 09, 2022 is available on the Company¬タルs website. | Download

Sequent Scientific Limited has informed the Exchange that the Recording of Analysts/Institutional Investor Meet/Con. Call held on August 09, 2022 is available on the Company¬タルs website. | Download

Cash Dividend 
Ex. DateSep 8, 2021

Final • Div/Share: ₹ 0.5

See all events